510(k) Report

510(k) · Cleared

Cleared

Nicore Model NCP-1 External Counterpulsation Device

K023016510(k) TraditionalCleared Dec 4, 200285-day reviewClass II21 CFR 870.5225

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Nicore Equipment & Leasing, Inc. · DRN Device, Counter-Pulsating, External

Cleared on Dec 4, 2002 after an 85-day review. The FDA summary names its predicate without a number. 8 later devices descend from it.

Decided
Dec 4, 2002
Review
85 days
Class
Class II
Product code
DRN
Recalls
None
Predicates
0

8 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2005: 1 descendant cleared2008: 1 descendant cleared2004: 1 descendant cleared2025: 1 descendant cleared2015: 1 descendant cleared2018: 1 descendant cleared2019: 1 descendant cleared2020: 1 descendant cleared200020052010201520202025
  1. This deviceK023016 Nicore Model NCP-1 External Counterpulsation DeviceNicore Equipment & Leasing, Inc. · 2002
  2. Descendant · cites it directly · 5 of its ownK042413 Acs Model NCP-2Applied Cardiac Systems · 2004
  3. Descendant · 2 generations on · 3 of its ownK152115 Renew NCP-5 External Counterpulsation SystemStage 2 Innovations · 2015
  4. Descendant · 3 generations on · 2 of its ownK173483 Pure Flow External Counter-Pulsation DeviceXtreem Pulse, LLC · 2018
  5. Descendant · 4 generations on · 1 of its ownK190683 External Counterpulsation SystemVamed Medical Instrument Co., Ltd. · 2019
  6. Descendant · 2 generations on · 0 of its ownK250756 Pression Wave PRO External Counter-Pulsation SystemPression, Inc. · 2025

Showing 5 of 8 descendants. See all descendants

Descendants cleared per year

2004: 12005: 12008: 12015: 12018: 12019: 12020: 12025: 1
2004high 1 (2004) · low 0 (2006)2026

Most influential descendants

Showing 5 of 8 · See all
  • K042413Acs Model NCP-2Applied Cardiac Systems · 2004 · cites it directly5descendants
  • K152115Renew NCP-5 External Counterpulsation SystemStage 2 Innovations · 2015 · 2 generations on3descendants
  • K173483Pure Flow External Counter-Pulsation DeviceXtreem Pulse, LLC · 2018 · 3 generations on2descendants
  • K190683External Counterpulsation SystemVamed Medical Instrument Co., Ltd. · 2019 · 4 generations on1descendant
  • K250756Pression Wave PRO External Counter-Pulsation SystemPression, Inc. · 2025 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K023016Nicore Model NCP-1 External Counterpulsation DeviceNicore Equipment & Leasing, Inc.2002—
+1K042413Acs Model NCP-2Applied Cardiac Systems2004—
+2K152115Renew NCP-5 External Counterpulsation SystemStage 2 Innovations2015—
+3K173483Pure Flow External Counter-Pulsation DeviceXtreem Pulse, LLC2018—
+4K190683External Counterpulsation SystemVamed Medical Instrument Co., Ltd.2019—
+2K250756Pression Wave PRO External Counter-Pulsation SystemPression, Inc.2025—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200410
200510
200810
201510
201810
201910
202010
202510
FIG. 1 — Lineage of K023016, 2002–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in DRN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new DRN device

  1. #1 K250756 Pression Wave PRO External Counter-Pulsation…score 10.8 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Vasomedical Model EECP-MC2
Named without a submission number
—

What descends from it? (8)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K042413Acs Model NCP-2Applied Cardiac Systems20045
K081359Genesis EcpScottcare Corporation20080
K050172Cardiassist Counter Pulsation System Series 4000/5000Cardiomedics, Inc.20050

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K042413 (Applied Cardiac Systems, 2004) has gone furthest, with 5 descendants of its own.

How does its category compare?

All DRN devices

DRN Device, Counter-Pulsating, External: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · DRN

1in 2025

2008: 12009: 12013: 12015: 12018: 12019: 12020: 22025: 1
2007high 2 (2020) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · DRN

Too few DRN 510(k)s in any year since 2007 to give a median.

Recalls per year · DRN

1in 2009

2009: 1
2007high 1 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · DRN

1in 2024

2007: 22016: 12024: 1
2007high 2 (2007) · low 0 (2008)2025

MAUDE reports naming product code DRN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—02
20081—00
20091—10
20100—00
20110—00
20120—00
20131—00
20140—00
20151—00
20160—01
20170—00
20181—00
20191—00
20202—00
20210—00
20220—00
20230—00
20240—01
20251—00
20260—0—

What is it indicated for?

The NICORE Model NCP-I is used to provide external counterpulsation (ECP) therapy, and is indicated for use in the treatment of

stable or unstable angina pectoris, congestive heart failure, cardiogenic shock,

and acute myocardial infarction.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K023016: Nicore Model NCP-1 External Counterpulsation Device.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K023016

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026